Figure 5.
IL-4 cytotoxin prolongs survival of animals bearing systemic Hodgkin disease. Beige/nude/X-linked BR immunodeficient mice injected intravenously with HD-MyZ cells (5 × 106/injection) were treated intraperitoneally with excipient (○) or IL438-37-PE38KDEL (100 μg/kg; 
) twice a day through days 7 to 11, and survival of the animals was observed. Each group contained 7 to 9 animals, and the experiment was performed twice with identical results.
